| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ferulic acid is an antioxidant found in some skin creams and serums. Foods: popcorn, bamboo, whole-grain rye bread, whole-grain oat flakes, sweet corn (cooked) Ferulic acid (FA) is a hydroxycinnamic acid abundant in plant cell walls (notably cereals/whole grains) with strong antioxidant and cytoprotective activity. Mechanistically, FA is frequently described as inducing Nrf2/HO-1 antioxidant programs and suppressing NF-κB-linked inflammation, with additional model-dependent anticancer effects (cell-cycle arrest, apoptosis, reduced invasion). Oral exposure is variable because FA is rapidly metabolized (often as conjugates) and bioaccessibility depends on the food matrix. -Ferulic acid found in dietary strand fractions, especially its free form, has important functions for protecting the human health. -AChE inhibitor (AD) -Cooking results in an increase in free ferulic acid quantity and in a reduction in bound ferulic acid quantity. Bamboo shoots 243.6 mg/100g Sugar-beet pulp 800 mg/100g Popcorn 313 mg/100g Wheat bran 500–1500mg/100g Whole wheat flour 100–300mg/100g
Pathway / Target Modulation by FA / Direction Aβ aggregation ↓ Inhibits fibril formation and destabilizes existing Aβ fibrils BACE‑1 & APP ↓ Reduces BACE-1 and APP expression; ↑ MMP‑2/‑9 expression promoting Aβ clearance Tau hyperphosphorylation Implicitly ↓ through modulation of Ca²⁺/CDK5/GSK3β pathways Ca²⁺ ↓ FA lowers STEP levels via chelation of Ca²⁺, suppressing PP2B → restores synaptic plasticity (AChE / BChE) ↓ Inhibition of AChE (FA IC₅₀~15 µM, derivatives IC₅₀ down to 0.006 µM); also BChE (MAO‑A/B) ↓ Inhibits MAO‑B (derivatives IC₅₀ ~0.3–0.7 µM), reducing ROS ROS ↓ Scavenges ROS, enhances antioxidant enzymes (e.g., catalase), ↓ MDA (COX‑2, 5‑LOX, NLRP3) ↓ Derivatives inhibit COX‑2/5‑LOX; derivative 13a ↓ NLRP3 inflammasome Iron/Cu²⁺ chelation ↓ Metal-induced Aβ aggregation via chelation by FA and derivatives Autophagy & Aβ clearance ↗ Suggested promotion of autophagy mechanisms targeting Aβ
Time-Scale Flag (TSF): P / R / G
|
| Source: | ||||||||||||||||||||||||||||||||
| Type: | ||||||||||||||||||||||||||||||||
| MFN1, MFN2, and OPA1 are mostly AD / neurodegeneration-relevant pathway targets: In AD, the general pattern is: fusion proteins MFN1, MFN2, and OPA1 tend to be reduced or functionally impaired, while fission signaling such as DRP1/FIS1 is often increased, contributing to fragmented mitochondria, synaptic injury, oxidative stress, and impaired bioenergetics MFN1, MFN2, and OPA1 are mitochondrial fusion regulators. MFN1 and MFN2 mediate outer mitochondrial membrane fusion, while OPA1 mediates inner mitochondrial membrane fusion and helps maintain cristae structure. In Alzheimer’s disease and related neurodegenerative models, mitochondrial dynamics are commonly shifted toward excessive fragmentation, with reduced or impaired fusion signaling and increased fission stress. Restoring MFN2/OPA1/MFN1 activity may help preserve mitochondrial network integrity, oxidative phosphorylation, neuronal transport, calcium handling, and synaptic resilience.
|
| 6416- | CUR, | QC, | FA, | RES, | EGCG | Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:77 Target#:1490 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid